Sana Biotechnology(SANA.US)

Last Updated 19:00:00 ET
longbridge loading

Sana Biotechnology Raises $69 Million Through Equity Offering

Tip Ranks·
US
SANA
+0.66%
US
SBIO
-1.24%
US
XBI
-0.69%
Tip Ranks·
US
SANA
+0.66%
US
SBIO
-1.24%
US
XBI
-0.69%

Sana Biotechnology (SANA) Receives a Buy from Wedbush

Tip Ranks·
US
SANA
+0.66%
US
LABD
+2.41%
US
FBT
+0.54%
Tip Ranks·
US
SANA
+0.66%
US
LABD
+2.41%
US
FBT
+0.54%

Sana Biotechnology | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
SANA
+0.66%
Earnings Watch·
US
SANA
+0.66%

Sana Biotechnology | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
SANA
+0.66%
Earnings Watch·
US
SANA
+0.66%

MileCell Biotechnology Launches New Corporate Website, Appoints Nianwei Lin, PhD, as CEO and Wayne Vaz as CCO

MorningStar·
US
SANA
+0.66%
US
IBBQ
+0.07%
US
XBI
-0.69%
MorningStar·
US
SANA
+0.66%
US
IBBQ
+0.07%
US
XBI
-0.69%

Sana Biotechnology (SANA) Is Up 6.3% After Mayo-Backed SC451 Diabetes Cell Therapy Collaboration - What's Changed

Simplywall·
US
SANA
+0.66%
US
XBI
-0.69%
US
IBBQ
+0.07%
Simplywall·
US
SANA
+0.66%
US
XBI
-0.69%
US
IBBQ
+0.07%

HC Wainwright Issues Positive Estimate for SANA Earnings

Market Beat·
US
SANA
+0.66%
US
IBB
+0.10%
US
XBI
-0.69%
Market Beat·
US
SANA
+0.66%
US
IBB
+0.10%
US
XBI
-0.69%

Sana Biotechnology shares are trading higher after the company announced a strategic collaboration with Mayo Clinic to advance development of SC451. Also, the company sold 7.5 million shares at $3.33 per share for $25 million to Mayo Clinic.

benzinga_article·
US
SANA
+0.66%
US
IBBQ
+0.07%
US
LABU
-2.35%
benzinga_article·
US
SANA
+0.66%
US
IBBQ
+0.07%
US
LABU
-2.35%
© 2026 Longbridge｜Disclaimer